Proactive Investors – Technology Minerals #TN1 hails Recyclus operation deal with battery collection group November 26, 2021 – Posted in: Technology Minerals (TM1)

Technology Minerals #TM1 – Chairman Robin Brundle joins Proactive London’s Katie Pilbeam about their 49% owned Recyclus Group signing a deal with Slicker Recycling to collect battery waste from around the UK and deliver it to its plants. Recyclus has unique technologies that allow it to reprocess both lead-acid and lithium-ion power units. Next year the business expects to deal with 16,000 tonnes of the former and 5,000 tonnes of the latter. Slicker Recycling has…

Tiziana CEO Kunwar Shailubhai discusses the company’s anti il6 technology to deliver drugs to lungs with Andrew Scott at Proactive Investors May 6, 2020 – Posted in: Tiziana Life Sciences (TILS)

Tiziana Life Sciences (LON:TILS)(NASDAQ:TLSA) CEO and chief scientific officer Kunwar Shailubhai discusses the recent excitement around inhalation and the direct delivery of drugs to lungs. ”It makes a lot of sense”, he says. Shailubhai says he’s pleased he’s covered this approach in his recent patent and in fact was one of the first to do it . ”COVID-19 grows in lungs, that’s where it proliferates and produces inflammation .. that leads to what’s known as…

Open Orphan #ORPH Exec Chairman Cathal Friel speaks to Proactive’s Andrew Scott about the new US biotech deal May 4, 2020 – Posted in: Open Orphan (ORPH)

Open Orphan PLC’s (LON:ORPH) Cathal Friel speaks to Proactive London’s Andrew Scott after signing a new deal with a US biotech for the provision of a respiratory syncytial virus human challenge study.

Open Orphan: Flu vaccine data showcased in peer reviewed article – Proactive Investors April 17, 2020 – Posted in: Open Orphan (ORPH)

by Ian Lyall. FLU-v has been developed by Imutex, 49%-owned by Open Orphan unit hVIVO The results of a successful phase IIb trial of a potential flu vaccine being developed by an Open Orphan PLC (LON:ORPH) joint-venture have been written up in a peer-reviewed article carried by a scientific journal. The data from FLU-v 004 challenge study underlined its ability to reduce mild-to-moderate symptoms of the illness. FLU-v has been developed by Imutex, 49%-owned by…

Proactive Investors – Open Orphan #ORPH catching global attention with ‘stunning’ FLU-v results & world-first coronavirus study March 12, 2020 – Posted in: Open Orphan (ORPH)

Open Orphan PLC‘s (LON:ORPH) Cathal Friel and its subsidiary hVIVO’s chief scientist Dr Andrew Catchpole sat down with Proactive London’s Andrew Scott. This morning Open Orphan announced the results from a clinical trial of a broad-spectrum flu jab that they’re jointly developing have been published in a peer-reviewed journal. The data from the FLU-v 003 phase IIb study of the FLU-v vaccine appeared in the Annals of Internal Medicine periodical. Also this week hVIVO began…

Proactive Investors interview with the Open Orphan #ORPH team on its future and ‘the lottery ticket’ sitting within hVIVO February 4, 2020 – Posted in: Open Orphan (ORPH)

Open Orphan PLC‘s (LON:ORPH) Cathal Friel speaks to Proactive London’s Andrew Scott following the completion last week of its £5.3mln fundraise. Also in studio is adviser to Open Orphan and founder of hVivo Professor John Oxford. Professor Oxford’s been a leader in the field of vaccine and anti-viral clinical trials for the last 20 years. hVivo, which has recently been acquired by Open Orphan, owns the largest commercial quarantine clinic in northern Europe and…

Cathal Friel, Open Orphan #ORPH CEO confirms to Proactive Investors that the hVIVO deal is done January 17, 2020 – Posted in: Open Orphan (ORPH)

Cathal Friel, CEO of Open Orphan announces that the hVIVO deal is finally in the bag and tells Proactive London what the timeline for shareholders now looks like. Cathal also provides some news on the Genomic Database and explains how he expects hVIVO to make a profit.

Kibo Energy (KIBO) – Proactive Investors Interview Q&A September 30, 2019 – Posted in: Kibo Energy (KIBO)

Kibo Energy PLC, the multi-asset, Africa focused, energy company, is pleased to release this Q&A, which summarises Proactive Investors’ interview with Kibo CEO Louis Coetzee regarding the reorganisation of the Company’s Botswanan Mabesekwa Coal Independent Power Project (‘MCIPP’) announced on 25 September 2019. Could you explain the reorganization of the MCIPP, announced on 25 September 2019? The Company has an 85% interest in a 303 million tonne (‘Mt’) coal resource in Botswana. On completion of the agreement, it will hold a 35-40% interest…

BigDish updates on new territory launches ahead of busy fourth quarter September 23, 2019 – Posted in: BigDish (DISH)

BigDish PLC’s (LON:DISH) Sanj Naha tells Proactive London’s Andrew Scott it’s been a busy time for them with new people joining and new locations launched.

Open Orphan #ORPH presents at Total Market Solutions & Proactive Investors’ One2One Forum, London September 16, 2019 – Posted in: Blog, Open Orphan (ORPH)

Open Orphan, a European-focussed, rare and orphan drug consulting services platform, is pleased to announce that on Wednesday 18th September the Company will be attending and presenting at Total Market Solutions, Moorgate, at 12:30pm and will also be attending and presenting at Proactive Investors’ One2One Forum at Chesterfield Mayfair Hotel, London, W1J 5EB from 18:00 onwards. Cathal Friel, Open Orphan’s Chief Executive Officer, will be in attendance throughout both events and will be presenting to update existing and potential investors on the Company’s business plans for…